AC
Amia Capital Portfolio holdings
AUM
$32.1M
1-Year Return
3.89%
This Quarter Return
-23.52%
1 Year Return
-3.89%
3 Year Return
+25.64%
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
-$231M
(-67%)
Cap. Flow
-$150M
Cap. Flow
% of AUM
-134.13%
Top 10 Holdings %
Top 10 Hldgs %
85.77%
Holding
48
New
6
Increased
2
Reduced
31
Closed
8
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$463K |
| 2 |
Arvinas
ARVN
|
$436K |
| 3 |
Scholar Rock
SRRK
|
$278K |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$250K |
| 5 |
Kezar Life Sciences
KZR
|
$59K |
Top Sells
Sector Composition
| 1 | Healthcare | 54.12% |
| 2 | Communication Services | 4.35% |
| 3 | Materials | 3.33% |
| 4 | Energy | 0.05% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
26
DELISTED
Sage Therapeutics
SAGE
| $320K | 0.28% |
11,159
-2,882
| -21% | -$82.6K |
|
|
MYOV
27
DELISTED
Myovant Sciences Ltd.
MYOV
| $317K | 0.28% |
41,970
-11,538
| -22% | -$87.1K |
|
|
AKCA
28
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $305K | 0.27% |
21,337
-6,880
| -24% | -$98.3K |
|
|
29
Scholar Rock
SRRK
$3.02B
| $278K | 0.25% |
+22,962
| New | +$278K |
|
30
CRISPR Therapeutics
CRSP
$4.99B
| $270K | 0.24% |
6,365
-2,062
| -24% | -$87.5K |
|
|
MTEM
31
DELISTED
Molecular Templates, Inc.
MTEM
| $250K | 0.22% |
+1,256
| New | +$250K |
|
32
MacroGenics
MGNX
$126M
| $229K | 0.2% |
39,389
-5,259
| -12% | -$30.6K |
|
33
Q32 Bio
QTTB
$20.4M
| $218K | 0.19% |
781
-363
| -32% | -$101K |
|
34
Sangamo Therapeutics
SGMO
$165M
| $214K | 0.19% |
33,555
-3,557
| -10% | -$22.7K |
|
35
Voyager Therapeutics
VYGR
$235M
| $214K | 0.19% |
23,360
+3,677
| +19% | +$33.7K |
|
36
Wave Life Sciences
WVE
$1.32B
| $196K | 0.17% |
20,943
+297
| +1% | +$2.78K |
|
|
37
Kezar Life Sciences
KZR
$29.8M
| $59K | 0.05% |
+1,352
| New | +$59K |
|
38
Cidara Therapeutics
CDTX
$1.6B
| $57K | 0.05% |
+1,153
| New | +$57K |
|
39
Petrobras
PBR
$78.7B
| $55K | 0.05% |
10,000
-790,000
| -99% | -$4.35M |
|
40
Bristol-Myers Squibb
BMY
$96B
| – | – |
-4,321
| Closed | -$277K |
|
41
iShares MSCI Chile ETF
ECH
$726M
| – | – |
-90,000
| Closed | -$3M |
|
42
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.5B
| – | – |
-586,300
| Closed | -$67.2M |
|
43
Gilead Sciences
GILD
$143B
| – | – |
-4,746
| Closed | -$308K |
|
44
Lennar Class B
LEN.B
$35.3B
| – | – |
-33,945
| Closed | -$1.44M |
|
45
Qiagen
QGEN
$10.3B
| – | – |
-64,937
| Closed | -$2.34M |
|
46
UBS Group
UBS
$128B
| – | – |
-25,840
| Closed | -$325K |
|
47
Technology Select Sector SPDR Fund
XLK
$84.1B
| – | – |
0
| – | – |
|
|
BOLD
48
DELISTED
Audentes Therapeutics, Inc
BOLD
| – | – |
-15,205
| Closed | -$910K |
|